Related Experiment Video
Updated: Sep 3, 2025
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Fear of progression in patients with mild or common type COVID-19
Shu Ding1, Liang Dong2, Lei Chen3
1Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Insights
Patients with mild COVID-19 experience low-to-moderate fear of disease progression. Unemployment and longer disease duration were associated factors. Psychological support is crucial for pandemic planning.
Area of Science:
- Psychiatry
- Public Health
- Infectious Diseases
Background:
- COVID-19 pandemic has caused global health crises.
- Fear of disease progression (FDP) in mild COVID-19 patients remains understudied.
- Understanding FDP is vital for psychological well-being during pandemics.
Purpose of the Study:
- To assess FDP levels in mild/common COVID-19 patients.
- To identify factors associated with FDP in this population.
- To inform psychological support strategies.
Main Methods:
- 114 mild/common COVID-19 patients were recruited from a Fangcang shelter hospital.
- The simplified Fear of Progression Questionnaire (Chinese version) assessed FDP.
- Multiple regression analysis identified associated factors.
Main Results:
- FDP scores were generally low-to-moderate.
- Unemployment, disease duration (≥28 days), and not having a spouse diagnosed with COVID-19 were associated with higher FDP.
- These findings highlight specific risk factors for FDP.
Conclusions:
- FDP is a significant psychological concern in COVID-19 patients.
- Psychological distress is a major pandemic impact.
- Integrating psychological support into pandemic planning is essential.
Aim:
To investigate the current condition and degree of fear of disease progression and associated factors in patients with mild or common type COVID-19.
Background:
At the end of 2019, COVID-19 spread from Wuhan in Hubei Province throughout China. Confirmed cases and deaths have since been reported in many countries around the world. However, fear of progression in these patients has been poorly explored.
Methods:
During February 2020, we recruited 114 patients with mild or common type COVID-19 admitted to a Fangcang shelter hospital. We assessed patients' degree of fear using the simplified Fear of Progression Questionnaire (Chinese version). Multiple regression analysis was applied to explore potential factors.
Results:
The fear of disease progression scores of patients with mild or common COVID-19 was at the low-to-moderate level. Current unemployment, disease duration of 28 days or more and not having a spouse diagnosed with COVID-19 were factors potentially associated with fear of progression.
Conclusion:
With a high prevalence of fear of disease progression in patients with COVID-19, the risk of psychological effects from the pandemic is significant and fear of progression is one of the manifestations. The need for psychological support services for patients should be included in all pandemic and disaster planning.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:29Pneumonia II: Pathophysiology